CoChat

Oxidative Damage Compromises Energy Metabolism in the Axonal Degeneration Mouse Model of X-Adrenoleukodystrophy

Open access
Galino, Jorge, Ruiz, Montserrat, Fourcade, Stéphane, Schlüter, Agatha, López-Erauskin, Jone, Guilera, Cristina, Jove, Mariona, Naudi, Alba, García-Arumí, Elena, Andreu, Antoni L., Starkov, Anatoly A., Pamplona, Reinald, Ferrer, Isidre, Portero-Otin, Manuel, Pujol, Aurora · 2011 · Antioxidants & Redox Signaling
Cited by 85

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

AIMS: Chronic metabolic impairment and oxidative stress are associated with the pathogenesis of axonal dysfunction in a growing number of neurodegenerative conditions. To investigate the intertwining of both noxious factors, we have chosen the mouse model of adrenoleukodystrophy (X-ALD), which exhibits axonal degeneration in spinal cords and motor disability. The disease is caused by loss of function of the ABCD1 transporter, involved in the import and degradation of very long-chain fatty acids (VLCFA) in peroxisomes. Oxidative stress due to VLCFA excess appears early in the neurodegenerative cascade. RESULTS: In this study, we demonstrate by redox proteomics that oxidative damage to proteins specifically affects five key enzymes of glycolysis and TCA (Tricarboxylic acid) cycle in spinal cords of Abcd1(-) mice and pyruvate kinase in human X-ALD fibroblasts. We also show that NADH and ATP levels are significantly diminished in these samples, together with decrease of pyruvate kinase activities and GSH levels, and increase of NADPH. INNOVATION: Treating Abcd1(-) mice with the antioxidants N-acetylcysteine and α-lipoic acid (LA) prevents protein oxidation; preserves NADH, NADPH, ATP, and GSH levels; and normalizes pyruvate kinase activity, which implies that oxidative stress provoked by VLCFA results in bioenergetic dysfunction, at a presymptomatic stage. CONCLUSION: Our results provide mechanistic insight into the beneficial effects of antioxidants and enhance the rationale for translation into clinical trials for X-adrenoleukodystrophy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/ars.2010.3877

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 51

  1. 10.1111/j.1582-4934.2008.00324.x · DOI · Paper page
  2. 10.1111/j.1471-4159.2009.05942.x · DOI · Paper page
  3. 10.1006/phrs.2000.0679 · DOI
  4. 10.1007/s10522-010-9301-8 · DOI
  5. 10.1016/j.bbadis.2010.06.006 · DOI
  6. 10.1016/j.nbd.2006.01.001 · DOI · Paper page
  7. 10.1111/j.1471-4159.2009.06397.x · DOI · Paper page
  8. 10.1089/ars.2009.3074 · DOI · Paper page
  9. 10.1007/s11064-010-0304-2 · DOI
  10. 10.1177/1533317508325093 · DOI · Paper page
  11. 10.1007/s11064-010-0295-z · DOI
  12. 10.1007/s10863-009-9243-5 · DOI · Paper page
  13. 10.1002/iub.352 · DOI
  14. 10.1093/hmg/ddq082 · DOI · Paper page
  15. 10.1016/j.bbadis.2009.08.010 · DOI · Paper page
  16. 10.1371/journal.pone.0005777 · DOI · Paper page
  17. 10.1016/B978-0-12-091302-2.50054-2 · doi:10.1016/b978-0-12-091302-2.50054-2
  18. 10.1016/S0014-5793(97)00029-X · DOI
  19. 10.1007/s11064-007-9466-y · DOI · Paper page
  20. 10.1016/j.neurobiolaging.2007.12.005 · DOI · Paper page
  21. 10.1038/ncb1881 · DOI · Paper page
  22. 10.1016/j.brainresrev.2009.10.003 · DOI · Paper page
  23. 10.1021/bi981512h · DOI · Paper page
  24. 10.1002/jcp.1041370102 · doi:10.1002/jcp.1041370102
  25. 10.1007/BF02705114 · DOI
  26. 10.1371/journal.pone.0006500 · DOI · Paper page
  27. 10.1089/ars.2007.1763 · DOI · Paper page
  28. 10.1038/nature05292 · DOI · Paper page
  29. López-Erauskin J Fourcade S Galino J Ruiz M Schlüter A Naudi A Jove M Portero-Otin M Pamplona R Ferrer I Pujol A. Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy. Ann Neurol (in press) DOI:10.1002/ana.22363 2011. · DOI · Paper page
  30. 10.1111/j.1750-3639.2009.00326.x · DOI · Paper page
  31. 10.3233/JAD-2007-12210 · DOI · Paper page
  32. 10.1074/jbc.M100320200 · DOI · Paper page
  33. 10.1016/S0891-5849(96)00269-9 · DOI · Paper page
  34. 10.1016/j.arr.2007.06.002 · DOI
  35. 10.1152/ajpcell.00232.2006 · DOI · Paper page
  36. 10.1002/jnr.22500 · DOI · Paper page
  37. 10.1111/j.1432-1033.1993.tb17638.x · DOI · Paper page
  38. 10.1177/1533317508325094 · DOI · Paper page
  39. 10.1073/pnas.0905529106 · DOI · Paper page
  40. 10.1006/abio.1998.2932 · DOI · Paper page
  41. 10.1081/DMR-100102336 · DOI · Paper page
  42. 10.1016/j.jns.2009.03.002 · DOI · Paper page
  43. 10.1111/j.1750-3639.2010.00392.x · DOI · Paper page
  44. 10.1016/j.arr.2008.07.003 · DOI
  45. 10.1523/JNEUROSCI.1899-04.2004 · DOI · Paper page
  46. 10.1074/jbc.M106798200 · DOI · Paper page
  47. 10.1016/j.addr.2008.05.001 · DOI
  48. 10.1523/JNEUROSCI.20-24-08972.2000 · DOI · Paper page
  49. 10.1098/rstb.2005.1764 · DOI · Paper page
  50. 10.1172/JCI34138 · DOI · Paper page
  51. 10.1016/j.abb.2009.03.001 · DOI

Cited by

See all 85

Metadata

Authors
Galino, J., Ruiz, M., Fourcade, S., Schlüter, A., López-Erauskin, J., Guilera, C., Jove, M., Naudi, A., García-Arumí, E., Andreu, A. L., Starkov, A. A., Pamplona, R., Ferrer, I., Portero-Otin, M., & Pujol, A.
Venue
Antioxidants & Redox Signaling
Published
2011-10-15
Volume
15
Issue
8
Pages
2095-2107
ISSN
  • 1523-0864 (ISSN-L)
  • 1557-7716
OpenAlex
W2033271062
Cited by
85
References
19
FWCI
5.79
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.